- Author
-
N.R. Bijsterveld
- Title
- Heparin derivatives in acute coronary syndromes
- Supervisors
- Co-supervisors
-
R.J.G. Peters
- Award date
- 19 March 2003
- Number of pages
- 146
- ISBN
- 9051706960
9789051706963 - Document type
- PhD thesis
- Faculty
- Faculty of Medicine (AMC-UvA)
- Note
- Research conducted at: CRIA
- Persistent Identifier
- https://hdl.handle.net/11245/1.211927
- Downloads
-
Thesis
Cover
Stellingen behorend bij het proefschrift
Titlepage
Contents
1 General Introduction
2 Low-molecular weight heparins in venous and arterial thrombotic disease
3 The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of lowmolecular weight heparin in the initial treatment of acute coronary syndromes
4 Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular weight heparin
5 Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: Results from the TIMI 11B and ESSENCE studies
6 Effects of clopidogrel on the rebound hypercoagulable state in acute coronary syndrome patients after heparin discontinuation
7 Ability of recombinant factor Vlla to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers
8 Recombinant factor Vlla reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
9 Summary and Discussion
10 Samenvatting
11 Dankwoord
12 Curriculum Vitae
Cover
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.